On June 25, the FDA
approved London-based GW Pharma’s Epidiolex, a drug containing CBD
as its active ingredient, to treat two rare and severe forms of
epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients
2 years old and older.
This is a major win for a
cannabis market that continues to entice
investors.
According to a recent
report by Hexa Research, the U.S. medical cannabis market is
projected to reach $19.48 billion by 2024.
We have now discovered a
little known CBD company CIIX (Chineseinvestors.com, Inc.) out of
Los Angeles, CA.. Start doing your own research on CIIX
immediately before the crowd discovers it. CIIX could be on
everyone’s screen a week from now, you are hearing it here
first. CIIX has an exciting CBD business, through its wholly
owned subsidiaries ChineseHempOil, Inc. and its websites
ChineseCBDOil.com and ChineseHempOil.com for online retail, and
direct sales of hemp based CBD products. CIIX is planning a
major revenue expansion domestically for its CBD/Hemp based
business. Those that discover CIIX now should be very happy
in the future.
A few companies with
important news in the sector include: Chineseinvestors.com, Inc.
(CIIX),
CV Sciences, Inc. (CVSI),
Aurora Cannabis (ABCFF),
GW Pharmaceuticals, Inc. (GWPH),
and Insys Therapeutics, Inc. (INSY).
Chineseinvestors.com, Inc.
(CIIX)
Market Cap: $11.07M
Share Price: $0.39
ChineseInvestors.com
(CIIX), a premier financial info website for Chinese-speaking
investors, is engaged in retail, online and direct sales of
hemp-based products and other health related products among several
other sectors, one being the crypto market. The company
recently announced the official launch of its new
cryptocurrency trading courses offered through its newly
established Bitcoin Trading Academy LLC. With its feet in two
of the hottest markets around, CBD and Crypto, CIIX is beginning to
turn heads in the investment community.
CV Sciences, Inc. (CVSI)
Market Cap: $282.86M
Share Price: $3.12
CV Sciences, Inc. is a
supplier and manufacturer of hemp-based phytocannabinoids including
cannabidiol (CBD) oil and developer of specialty pharmaceutical
therapeutics. The Company recently had news showing unaudited
second quarter 2018 revenue. Second quarter 2018 revenue is
expected to be USD 12.3 Million, up over 200% to the second quarter
of 2017. Investors have hopped on this news pushing CVSI
into the green over the past few sessions.
Aurora Cannabis (ABCFF)
Market Cap: $3.11B
Share Price: $5.45
Another CBD company
receiving investor interest from recent new is Aurora Cannabis Inc.
(ACBFF). The company recently received a Letter of Intent to
establish one of the first medical cannabis production facilities
in Malta. The Company received a Letter of Intent from Malta
Enterprise for the establishment of a seed-to-pharma cannabis
operation, including the construction of a hybrid production
facility that will be focused predominantly on the production of
oils and derivatives. Operations will be carried out by a new
company, to be formed by Aurora and its local partner Cherubino
Ltd., the largest pharmaceutical wholesaler in Malta with an
operating history of over 100 years. Aurora will be the majority
shareholder in the new venture.
GW Pharmaceuticals, Inc.
(GWPH)
Market Cap: $3.80B
Share Price: $135.07
Referenced earlier in this
report, GW Pharmaceuticals, Inc. (GWPH), has investors on the edge
of their seats. The company is preparing to announce their
fiscal 3rd quarter results August 7th on a conference call at 4:30
pm. The stock’s performance has been mixed as investors
prepare for the call.
Insys Therapeutics, Inc.
(INSY)
Market Cap: $491.56M
Share Price: $6.66
Not all CBD companies have
had positive news, Friday, Insys Therapeutics, Inc announced the
U.S. Food and Drug Administration declined to approve its opioid
painkiller, citing potential safety concerns. Insys' treatment is
an under-the-tongue spray formulation of the opioid buprenorphine
that was under review to treat moderate-to-severe pain.
Despite the news, the stock has started to rebound as investors
look for the company to rebound from this news.
Conclusion:
With investor interest
squarely growing on the CBD, lesser known quantities such as CIIX
may be prime for an influx of attention making this a good time for
investors to consider CIIX.
Legal
Disclaimer
Except for the historical
information presented herein, matters discussed in this article
contain forward-looking statements that are subject to certain
risks and uncertainties that could cause actual results to differ
materially from any future results, performance or achievements
expressed or implied by such statements. ACR Communication, LLC,
which owns Microcapspeculators.com, is not registered with Finra or
any other financial or securities regulatory authority, and does
not provide nor claims to provide investment advice or
recommendations to readers of this release. ACR Communication, LLC
[and/or] Microcapspeculators.com does not have a position in the
securities mentioned herein and may increase or decrease such
positions without notice. For making specific investment decisions,
readers should seek their own advice. ACR Communication LLC, which
owns Microcapspeculators.com, is compensated for its services in
the form of cash-based compensation or in equity in the companies
it writes about, or a combination of the two. ACR
Communication, LLC has been compensated one thousand dollars cash
for this article and one thousand dollars total by Regal
Consulting. LLC, for news commentary articles for CIIX. CIIX
and Regal Consulting, LLC were given an opportunity to edit
information included in this article. This article is based
solely on public information and the opinions of ACR Communication,
LLC, which believes the news commentary to include accurate and
complete information. ACR Communication, LLC, will not buy or
sell any shares in stocks contained within this article for forty
eight hours after this article’s distribution.
For Full Legal Disclaimer
Click Here.
Contact
Information:
Company
Name: Microcap Speculators
Contact
Person: Media Manager
Email:
info@microcapspecualtors.com
Phone:
1-702-720-6310
Country:
United States
Website:
http://microcapspeculators.com/
Abacus Mining and Explor... (PK) (USOTC:ABCFF)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Abacus Mining and Explor... (PK) (USOTC:ABCFF)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
